SLC7A1 and metabolic syndrome: ExomiR-122-5p has been observed to have a crucial role in metabolism of cholesterol by targeting Cationic amino acid transporter 1 (CAT1), which transports cationic amino acids (Figure 3) and can be linked to dyslipidemia in PE (62).